Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 13 (4), 473-480
- https://doi.org/10.3109/02652049609026032
Abstract
This study was undertaken to establish experimentally whether the intravitreal application of liposomally-entrapped ganciclovir could prolong intraocular therapeutic levels when it is compared to the intravitreal injection of a simple solution of the drug. New Zealand white rabbits were given an intravitreal injection of the drug solution and of liposome-encapsulated ganciclovir. The intravitreal clearance of ganciclovir was determined after a single injection of either the drug solution (200 micrograms/0.1 mL) or the liposomally-entrapped (with 41% load; 82 micrograms drug load and 118 micrograms free) ganciclovir. The ganciclovir vitreal concentrations were measured at various time intervals for a period up to 43 days using an HPLC method. The results of this study clearly demonstrated that prolonged intravitreal drug levels (above the mean inhibitory dose of cytomegalovirus of 1 microgram/mL) after administration of the liposome-entrapped ganciclovir and estimated to continue beyond 30-43 days. The injection of the 200 micrograms/0.1 mL of drug solution showed a mean vitreous concentration which was higher than the ID50 only for 55 h. The disappearance rate constant for the liposome-encapsulated injections was approximately 22 x slower than simple drug solution injections (controls). No evidence of retinal toxicity was found by clinical or light microscopy examination of the treated eyes.Keywords
This publication has 14 references indexed in Scilit:
- Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.British Journal of Ophthalmology, 1994
- RETINAL TOXICITY OF HIGH DOSE INTRAVITREAL GANCICLOVIRRetina, 1994
- Pathology of Cytomegalovirus Retinitis Treated with Sustained Release Intravitreal GanciclovirOphthalmology, 1993
- Sustained-Release Ganciclovir Therapy for Treatment of Cytomegalovirus RetinitisArchives of Ophthalmology (1950), 1992
- Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patientsDocumenta Ophthalmologica, 1992
- GanciclovirDrugs, 1990
- Treatment of Cytomegalovirus Retinitis with Intravitreal GanciclovirOphthalmology, 1989
- Use of Intravitreal Ganciclovir (Dihydroxy Propoxymethyl Guanine) for Cytomegalovirus Retinitis in a Patient With AIDSAmerican Journal of Ophthalmology, 1987
- INTRAVITREAL INJECTION OF LIPOSOME-ENCAPSULATED GANCICLOVIR IN A RABBIT MODELRetina, 1987
- Intravitreal Toxicity of Hydroxyacyclovir (BW-B759U), a New Antiviral AgentArchives of Ophthalmology (1950), 1985